IVOSX | JVMAX | IVOSX / JVMAX | |
Total Expense Ratio | 0.73 | 1.12 | 65% |
Annual Report Gross Expense Ratio | 0.93 | 1.13 | 82% |
Fund Existence | 11 years | 28 years | - |
Gain YTD | 4.455 | 3.580 | 124% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 921M | 21.7B | 4% |
Annual Yield % from dividends | 1.76 | 0.60 | 296% |
Returns for 1 year | -0.70 | -2.54 | 28% |
Returns for 3 years | 20.33 | 16.43 | 124% |
Returns for 5 years | 50.14 | 50.75 | 99% |
Returns for 10 years | 94.30 | 33.14 | 285% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SDP | 14.25 | 0.18 | +1.28% |
ProShares UltraShort Utilities | |||
FRA | 12.92 | 0.01 | +0.11% |
Blackrock Floating Rate Income Strategies Fund | |||
FIAX | 18.26 | -0.01 | -0.05% |
Nicholas Fixed Income Alternative ETF | |||
NULV | 40.71 | -0.46 | -1.12% |
Nuveen ESG Large-Cap Value ETF | |||
BIB | 47.37 | -0.62 | -1.29% |
ProShares Ultra Nasdaq Biotechnology |